- Home
- PBHC vs ATRA Comparison
PBHC vs ATRA Comparison
Compare PBHC & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PBHC | ATRA |
|---|---|---|
| Founded | 1859 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.5M | 81.2M |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | PBHC | ATRA |
|---|---|---|
| Price | $16.50 | $9.38 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 3.6K | ★ 46.0K |
| Earning Date | 04-29-2026 | 05-13-2026 |
| Dividend Yield | ★ 2.94% | N/A |
| EPS Growth | 46.25 | ★ 122.52 |
| EPS | ★ 0.47 | N/A |
| Revenue | N/A | ★ $120,772,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $35.11 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.06 | $3.92 |
| 52 Week High | $17.40 | $19.15 |
Technical Indicators
Market Signals| Indicator | PBHC | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 55.85 | 57.43 |
| Support Level | $15.50 | $9.03 |
| Resistance Level | $17.05 | $11.17 |
| Average True Range (ATR) | 0.29 | 0.66 |
| MACD | 0.00 | 0.16 |
| Stochastic Oscillator | 40.98 | 83.84 |
Price Performance
Historical ComparisonAbout PBHC Pathfinder Bancorp Inc. (MD)
Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.